Acticor Biotech (XPAR:ALACT) Ending Cash Position : €7.96 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Ending Cash Position?

Acticor Biotech's Ending Cash Position for the quarter that ended in Jun. 2023 was €7.96 Mil.

Acticor Biotech's quarterly Ending Cash Position increased from Jun. 2022 (€4.89 Mil) to Dec. 2022 (€6.60 Mil) and increased from Dec. 2022 (€6.60 Mil) to Jun. 2023 (€7.96 Mil).

Acticor Biotech's annual Ending Cash Position increased from Dec. 2020 (€7.59 Mil) to Dec. 2021 (€11.35 Mil) but then declined from Dec. 2021 (€11.35 Mil) to Dec. 2022 (€6.60 Mil).

Acticor Biotech Ending Cash Position Historical Data

The historical data trend for Acticor Biotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Ending Cash Position Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Ending Cash Position

Get a 7-Day Free Trial

10.19

12.88

7.59

11.35

6.60

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Ending Cash Position	Get a 7-Day Free Trial				8.80	11.35	4.89	6.60	7.96

Acticor Biotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Acticor Biotech's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.348	+	-4.749
	=	6.60

Acticor Biotech's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.599	+	1.356
	=	7.96

Acticor Biotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines